ZLD

0.00%

69.0¢ zelira therapeutics limited

Loving your posts tas!! Always informative and you always...

First 95 Last

Share
Profile

Follow
Patzilla

50 Posts.

16

02/02/21

09:41

Post #: 50629086
Share

Originally posted by tas_mc_investor: ↑

@FiSaver is correct. Zelira aren't selling anything at all in Louisiana. They 'sold' a licensing deal to a company in that state, and are awaiting first receipt of royalty revenues. These, by their nature, can't be reported in quarterly or real time, as (I would imagine), each licensee will process their accounts either quarterly or half-yearly, and then distribute royalties in the subsequent quarterly or half-yearly period.

Anyway. I suspect the case with Zelira will be we don't see much revenue for some time, and then all of a sudden one day we'll be asking ourselves "wow, where did all that coin come from all of a sudden." I have tempered expectations in that regard. I'll be enjoying the newsflow this year. Remember, the company aims to have 15 products in the market by the end of the year. Next order/s of business we will likely hear about will probably be Parkinsons formula license deal/product release in the states, introduction of Hope and Zenivol into the German market, and the start of the rollout of the dermatology line in collab with Karyn Grossman. Reviewing the Sequoia research report (you can find this on the Zelira website, under reports), it appears we have a 80/20 revenue split with K.G. for the derma line, in our favour.

Expand

Loving your posts tas!! Always informative and you always produce evidence not like the down rampers that like to throw wild baseless accusations around

ZLD Price at posting: 7.9¢ Sentiment: Hold Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

There are more pages in this discussion • 8 more messages in this thread...

First 95 Last

Add ZLD (ASX) to my watchlist

(20min delay)
Last 69.0¢		Change 0.000(0.00%)		Mkt cap ! $7.829M

Open	High	Low	Value	Volume
67.0¢	69.0¢	67.0¢	$752	1.122K

Buyers (Bids)

No.	Vol.	Price($)
2	7248	67.0¢

Sellers (Offers)

Price($)	Vol.	No.
73.5¢	13966	2

View Market Depth

No.	Vol.	Price($)
2	7248	0.670
2	5881	0.650
1	9000	0.600
1	1400	0.560
1	2000	0.550

Price($)	Vol.	No.
0.735	13966	2
0.740	45	1
0.750	871	2
0.760	1154	2
0.790	618	2

Last trade - 14.11pm 06/09/2024 (20 minute delay)

ZLD (ASX) Chart

Loving your posts tas!! Always informative and you always...

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Shekel Brainweigh investor presentation webinar – the future of retail automation

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Loving your posts tas!! Always informative and you always...

Top Stories

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Shekel Brainweigh investor presentation webinar – the future of retail automation

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News